8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Cyclacel Pharmaceuticals Reports SECOND quarter financial results and provides business update
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
D: Filing D
10-Q: Q1 2024 Earnings Report
8-K: Cyclacel Pharmaceuticals Reports first quarter financial results and provides business update
EFFECT: Others
424B3: Prospectus
UPLOAD: Others
CORRESP: CORRESP
ARS: Annual Report to Security Holders
DEFA14A: Others
DEF 14A: Definitive information statements
No Data
No Data